Rossi AJ, Khan TM, Hong H, Lesinski GB, et al. Pepinemab (Anti-SEMA4D) in Combination with Ipilimumab or Nivolumab for Patients
with Resectable Pancreatic and Colorectal Cancer. Ann Surg Oncol 2021 May 13. pii: 10.1245/s10434-021-10111.
PMID: 33987757